TITLE

Drug companies face pressure on profits

AUTHOR(S)
Josefson, Deborah
PUB. DATE
January 2002
SOURCE
BMJ: British Medical Journal (International Edition);1/12/2002, Vol. 324 Issue 7329, p65
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on pressure related to profits facing major pharmaceutical corporations in the United States. Expected impact on drug companies such as Merck, Bristol-Myers Squibb, Eli Lilly, Schering-Plough, and Pharmacia; Impact on popular prescription brand name drugs and their generic equivalents; How reduced profits may endanger investment in research and development and ultimately future healthcare progress; Comparison to Canada and much of Europe where prescription drug costs are regulated by government; Impact of higher drug prices.
ACCESSION #
5911550

 

Related Articles

  • The Pill Machine. Miller, Karen Lowry // Newsweek (Atlantic Edition);11/19/2001 (Atlantic Edition), Vol. 138 Issue 21, p44 

    Focuses on the increased efforts of large drug companies to help developing countries by reducing the costs of their drugs. Pioneering work of Merck pharmaceuticals to promote Western philanthropy; Debate at the World Trade Organization summit; Pressures on Western firms to drop drug prices for...

  • Another Pharma Major Persuaded.  // Latin America Monitor: Brazil Monitor;Jan2004, Vol. 21 Issue 1, p8 

    Reports that the Brazilian government has persuaded pharmaceutical company Merck to slash the price of its anti-retroviral drug Efavirenz as of December 2003. Percentage of price reduction; Conditions expressed by the Brazilian government if big pharmaceutical multinationals did not lower the...

  • Is Merck cheap?  // Dow Theory Forecasts;12/8/2003, Vol. 59 Issue 49, p8 

    Focuses on the performance of Merck & Co. Inc. in the stock market in the U.S. Challenges faced by the company regarding the patent expiration of one of its products; Company operations; Speculation of worst case valuations for the company.

  • WALL STREET CHOICE: MERCK, A RENAISSANCE IN THE MAKING. Butler, C. Anthony // Medical Marketing & Media;May2003, Vol. 38 Issue 5, p36 

    Analyzes the stocks of pharmaceutical firm Merck & Co. Inc. in the U.S. Flat earnings growth for 2002; International competition faced by Merck's drug Zocor; Merck's joint venture with Schering-Plough Corp.

  • WALL STREET CHOICE: MERCK FACES PIPELINE ISSUES.  // Medical Marketing & Media;Oct2003, Vol. 38 Issue 10, p32 

    Rates the stocks of pharmaceutical company Merck and Co. Inc. Underperformance of Merck shares; Lack of near-term new products; Long-term exclusivity issues for U.S. Zocor sales.

  • Merck Warning Shocks Industry.  // Chemical Market Reporter;12/17/2001, Vol. 260 Issue 23, p2 

    Reports on the announcement of pharmaceutical company Merck concerning its earnings outlook for 2002. Effect of the announcement on the company's stock; Percentage of the decline in the value of the company's stock; Speculations on the reason for the announcement.

  • Quarterly Reports.  // Contract Pharma;Mar2013, Vol. 15 Issue 2, p133 

    The article discusses the revenues and earnings of several pharmaceutical industries for 2012. Pfizer Inc.'s revenues in the U.S. were 9% down due to the loss of exclusivity for Lipitor and Geodon drugs. Merck & Co. Inc.'s sales were 6% down due to foreign exchange. AstraZeneca PLC's revenues...

  • DRUG TRIPS. Gibbs, Lisa // Money;Sep2001, Vol. 30 Issue 9, p118 

    Details the trip of Americans who go to Canada to buy prescription drugs because of the high cost of drugs in the United States. How prescriptions can be filled for a three month supply and one refill; Issue of legality of the process, according to the U.S. Food and Drug Administration; Focus...

  • Stock to watch: Merck. Garret, Rob // Business News New Jersey;11/30/98, Vol. 11 Issue 43, p14 

    Looks at the stock performance of Whitehouse Station, New Jersey-based pharmaceutical firm Merck & Co. from June to November 1998. Merck's share price in the $156 range; Approval sought by the Merck for its Vioxx drug from the Food and Drug Administration.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics